Show simple item record

dc.contributor.authorMcCormick, Benjamin J.J.
dc.contributor.authorWaiswa, Peter
dc.contributor.authorNalwadda, Celia
dc.contributor.authorSewankambo, Nelson K.
dc.contributor.authorKnobler, Stacey L.
dc.date.accessioned2021-03-17T10:25:01Z
dc.date.available2021-03-17T10:25:01Z
dc.date.issued2020-11-25
dc.identifier.citationMcCormick , B J J , Waiswa , P , Nalwadda , C , Sewankambo , N K & Knobler , S L 2020 , ' SMART Vaccines 2.0 decision-support platform : A tool to facilitate and promote priority setting for sustainable vaccination in resource-limited settings ' , BMJ Global Health , vol. 5 , no. 11 , e003587 . https://doi.org/10.1136/bmjgh-2020-003587en
dc.identifier.issn2059-7908
dc.identifier.otherPURE: 187594880
dc.identifier.otherPURE UUID: df33ea27-495a-4960-9569-546f6226df5e
dc.identifier.otherScopus: 85097228865
dc.identifier.urihttps://hdl.handle.net/2164/16060
dc.descriptionFunding Information: Supported by Gavi and the Bill and Melinda Gates Foundation, a number of international organisations have offered capacity-building support to establish NITAGs. While greater emphasis was initially placed on fulfilling process indicators for establishing NITAGs, more recent efforts have sought to advance functional capabilities associated with EIDM, most notably by Agence de Médecine Préventive (AMP), the International Vaccine Institute and The Sabin Vaccine Institute.13 14 These programmes have additionally leveraged technical assistance from WHO and its regional offices, PATH and the US Centers for Disease Control and Prevention.15 16 Funding Information: The UNITAG sought technical assistance from AMP’s Supporting Independent Vaccine Advisory Committees (SIVAC) Initiative,14and engaged in piloting the SMART Vaccines 2.0 platform supported by the Fogarty International Center at the US National Institutes of Health (NIH). A description of the NITAG process is given elsewhere.24 33 Funding Information: Funding This work was supported by the Fogarty International Center, National Institutes of Health, USA. Publisher Copyright: © 2020 Author(s). Published by BMJ.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofBMJ Global Healthen
dc.rightsOpen access: This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en
dc.subjecthealth policyen
dc.subjectimmunisationen
dc.subjectpublic healthen
dc.subjectvaccinesen
dc.subjectR Medicine (General)en
dc.subjectHealth Policyen
dc.subjectPublic Health, Environmental and Occupational Healthen
dc.subject.lccR1en
dc.titleSMART Vaccines 2.0 decision-support platform : A tool to facilitate and promote priority setting for sustainable vaccination in resource-limited settingsen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmjgh-2020-003587
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85097228865&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record